{"version":"1.0","provider_name":"Neuraxpharm Espa\u00f1a","provider_url":"https:\/\/www.neuraxpharm.com\/es","author_name":"victorgonzalez60","author_url":"https:\/\/www.neuraxpharm.com\/es\/blog\/autor\/victorgonzalez60","title":"Caso 2 homotaurina: s\u00edndrome DCL","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"i1E6yxWJ7b\"><a href=\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/caso-2-homotaurina-sindrome-dcl\">Caso 2 homotaurina: s\u00edndrome DCL<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/es\/medico\/materiales-cientificos\/caso-2-homotaurina-sindrome-dcl\/embed#?secret=i1E6yxWJ7b\" width=\"600\" height=\"338\" title=\"\u00abCaso 2 homotaurina: s\u00edndrome DCL\u00bb \u2014 Neuraxpharm Espa\u00f1a\" data-secret=\"i1E6yxWJ7b\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/es\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.neuraxpharm.com\/es\/wp-content\/uploads\/sites\/8\/2021\/06\/caso-2-homotaurina.jpg","thumbnail_width":1944,"thumbnail_height":979,"description":"\"Deterioro cognitivo ligero y S\u00edndrome de Charles Bonnet\" es el segundo de una serie de cuatro casos cl\u00ednicos con homotaurina en los que se exponen los antecedentes personales, enfermedades, exploraciones neurol\u00f3gicas, pruebas diagn\u00f3sticas y resoluci\u00f3n final del caso."}